UNSPSC 51171943: Glaziovine

This classification denotes an anti-ulcer agent with the molecular formula C18H19NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KE7J8A65P6, chemically known as spiro(2,5-cyclohexadiene-1,7(1h)-cyclopent(ij)isoquinolin)-4-one, 2,3,8,8a-tetrahydro-6-hydroxy-5-methoxy-1-methyl-, (+-)- (9ci) but generally known as glaziovine, which bears US NIH Compound Identifier 65631. European Medicines Agency schedules Glaziovine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07911MIG.

UNSPSC 51171943 Glaziovine is a Commodity code under which state and local governments procure pharmaceutical products, particularly generic multi-source drugs and over-the-counter medications supplied through authorized wholesale channels and direct-to-manufacturer arrangements. The work being solicited spans generic pharmaceutical distribution via cooperative purchasing agreements, direct pharmacy benefit management programs, and specialized drug testing and specimen collection services that require laboratory certification and SAMHSA compliance. Issuing bodies include state health and human services commissions, county criminal justice departments, and multistate cooperative purchasing alliances administering agreements for participating state and local government facilities across multiple jurisdictions.

Recent activity shows geographic spread across Texas and Minnesota-led multistate cooperative activity. The Collin County Community Supervision and Corrections Department (Texas) issued RFP 2026-327 for offender specimen collection and drug testing services with a response deadline of July 23, 2026 and estimated contract value of $600,000 over two years with optional renewal periods; the solicitation covers immunoassay screening, LC/MS/MS or GC/MS confirmation, and alternative testing methodologies across two collection sites. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products with a proposal deadline of March 26, 2026, requiring vendors to supply through authorized wholesalers including AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC with contract effectiveness on July 1, 2026. The Texas Health and Human Services Commission issued RFI HHS0017013 (posted April 3, 2026) to gather market intelligence on implementing a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking vendor capabilities for direct contracting with self-insured health plans outside traditional pharmacy benefit manager and group purchasing organization channels.